Meeting
2022 ASCO Genitourinary Cancers Symposium
Waning efficacy of COVID-19 vaccination at six months in patients (pts) with genitourinary malignancies.
Authors
Zeynep Busra Zengin
City of Hope Comprehensive Cancer Center, Duarte, CA
Zeynep Busra Zengin , Luis A Meza , Jasnoor Malhotra , Sabrina Salgia , Jennifer Ely , Joann Hsu , Erin Kelley , Heather Mead , Nazli Dizman , Alex Chehrazi-Raffle , Ameish Govindarajan , Ramya Muddasani , Neal Shiv Chawla , Tanya B. Dorff , Yung Lyou , Ewa Karczewska , Jeffrey M. Trent , Ravi Salgia , John Altin , Sumanta K. Pal
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Other
Citation
J Clin Oncol 40, 2022 (suppl 6; abstr 185)
DOI
10.1200/JCO.2022.40.6_suppl.185
Abstract #
185
Poster Bd #
K3
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Efficacy of COVID vaccinations in patients with chronic lymphocytic leukemia.
First Author: Kaitlin Annunzio
Poster
2023 ASCO Genitourinary Cancers Symposium
Clinical characteristics and outcomes of SARS-CoV-2 infection in patients with genitourinary cancer.
First Author: Dorothy Kenny
Poster
2021 ASCO Quality Care Symposium
Safety and efficacy of COVID-19 vaccination in patients receiving systemic anticancer therapy.
First Author: Mahir Khan
Poster
2023 ASCO Quality Care Symposium
Improving bivalent COVID-19 vaccination rates among adult patients with cancer: An ASCO/CDC initiative.
First Author: Michael Jisoo Lee